Literature DB >> 861596

Immunoreactive beta-melanocyte-stimulating hormone in cerebrospinal fluid and plasma in hypopituitarism: evidence for an extrapituitary origin.

S Shuster, A Smith, N Plummer, A Thody, F Clark.   

Abstract

Immunoreactive beta-melanocyte-stimulating hormone (beta-MSH) was measured in the plasma of 19 patients with hypopituitarism and in the cerebrospinal fluid (CSF) of five of these patients. In neither plasma nor CSF were the beta-MSH concentrations significantly different from those in normal controls. These observations raise the possibility that beta-MSH may be produced by and secreted from neural tissue; this is supported by the findings of beta-MSH in high concentrations in many parts of the brain.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 861596      PMCID: PMC1607129          DOI: 10.1136/bmj.1.6072.1318

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  ACTH, alpha-MSH and beta-LPH: pituitary hormones with similar activity in an amnesia test in rats.

Authors:  H Rigter; S Shuster; A J Thody
Journal:  J Pharm Pharmacol       Date:  1977-02       Impact factor: 3.765

2.  Commentary: behaviourally active ACTH analogues.

Authors:  D de Wied; A Witter; H M Greven
Journal:  Biochem Pharmacol       Date:  1975-08-15       Impact factor: 5.858

3.  Endorphins, brain peptides that act like opiates.

Authors:  R Guillemin
Journal:  N Engl J Med       Date:  1977-01-27       Impact factor: 91.245

4.  A radioimmunoassay for beta-melanocyte-stimulating hormone in human plasma.

Authors:  A J Thody; N A Plummer
Journal:  J Endocrinol       Date:  1973-08       Impact factor: 4.286

5.  A reappraisal of human beta MSH.

Authors:  G A Bloomfield; A P Scott; P J Lowry; J J Gilkes; L H Rees
Journal:  Nature       Date:  1974-12-06       Impact factor: 49.962

6.  Circulating corticotrophin levels in severe hypopituitarism and in the neonate.

Authors:  I M Holdaway; L H Rees; J Landon
Journal:  Lancet       Date:  1973-11-24       Impact factor: 79.321

7.  Immunoreactive beta-melanocyte-stimulating hormone in cerebrospinal fluid.

Authors:  A G Smith; S Shuster
Journal:  Lancet       Date:  1976-06-19       Impact factor: 79.321

8.  On a possible role of beta-melanocyte stimulating hormone (beta-MSH) in the central nervous system of the Mammalia: an effect of beta-MSH in the spinal cord of the cat.

Authors:  W A KRIVOY; R GUILLEMIN
Journal:  Endocrinology       Date:  1961-07       Impact factor: 4.736

9.  Cerebrospinal fluid hormone concentration in the evaluation of pituitary tumors.

Authors:  R M Jordan; J W Kendall; J L Seaich; J P Allen; C A Paulsen; C W Kerber; W P Vanderlaan
Journal:  Ann Intern Med       Date:  1976-07       Impact factor: 25.391

10.  Behavioral inhibition as modified by melanocyte-stimulating hormone (MSH) and light-dark conditions.

Authors:  C A Sandman; A J Kastin; A V Schally
Journal:  Physiol Behav       Date:  1971-01
View more
  4 in total

1.  Neural tube defects and immunoreactive beta-melanocyte-stimulating hormone in amniotic fluid.

Authors:  A G Smith; S Shuster; D Clark; A J Thody; E V Davison; A M Ward
Journal:  Br Med J       Date:  1978-07-01

2.  The association between the melanocyte-stimulating hormone receptor and the alpha 2-adrenoceptor on the Anolis melanophore.

Authors:  R J Carter; S Shuster
Journal:  Br J Pharmacol       Date:  1982-01       Impact factor: 8.739

3.  Gastro-intestinal and neurohormonal peptides in the alimentary tract and cerebral complex of Ciona intestinalis (Ascidiaceae).

Authors:  H A Fritsch; S Van Noorden; A G Pearse
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

4.  The orphan G protein-coupled receptor GPR139 is activated by the peptides: Adrenocorticotropic hormone (ACTH), α-, and β-melanocyte stimulating hormone (α-MSH, and β-MSH), and the conserved core motif HFRW.

Authors:  Anne Cathrine Nøhr; Mohamed A Shehata; Alexander S Hauser; Vignir Isberg; Jacek Mokrosinski; Kirsten B Andersen; I Sadaf Farooqi; Daniel Sejer Pedersen; David E Gloriam; Hans Bräuner-Osborne
Journal:  Neurochem Int       Date:  2016-12-01       Impact factor: 3.921

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.